Dr. Oren Smaletz

Dr. Dr. Oren Smaletz

Sao Paulo, Brazil

Dr. Oren Smaletz – Clinical Oncologist in Brazil

Dr. Oren Smaletz is an experienced clinical oncologist in São Paulo, Brazil, associated with Hospital Israelita Albert Einstein. His professional career combines clinical oncology, advanced cancer treatment, medical education, and scientific research. He has particular professional experience in genitourinary oncology, with a focus on cancers such as prostate and testicular cancer. His work also includes participation in educational programs and scientific discussions concerning modern cancer diagnosis and treatment.

Dr. Smaletz graduated in Medicine from the Faculty of Medicine of the University of São Paulo (FMUSP) in 1995. He subsequently completed a residency in Clinical Medicine at Hospital das Clínicas, FMUSP, between 1996 and 1998. He then pursued specialized training in Clinical Oncology at Memorial Sloan Kettering Cancer Center in New York, completing the program between 1999 and 2002. This combination of Brazilian medical education and specialized oncology training in the United States forms an important part of his professional background.

Specialization in Clinical Oncology

Dr. Oren Smaletz specializes in clinical oncology, a medical field focused on the diagnosis, systemic treatment, and ongoing management of patients with cancer. His professional profile at Albert Einstein identifies him as a clinical oncologist, while medical organizations specifically identify his clinical focus as including prostate and testicular cancers.

Modern clinical oncology may involve several forms of treatment, including chemotherapy, hormone-based treatment, targeted therapies, immunotherapy, and other systemic approaches. The appropriate treatment depends on the cancer type, stage, molecular characteristics, previous therapies, overall health, and individual patient circumstances.

Dr. Smaletz's professional and academic activities demonstrate an interest in contemporary cancer treatment and evidence-based oncology. His research and educational work have included subjects related to prostate cancer, genitourinary tumors, and emerging approaches to cancer management.

Expertise in Prostate Cancer

One of Dr. Smaletz's principal areas of clinical interest is prostate cancer. He has contributed to scientific publications concerning systemic treatment for advanced prostate cancer and has participated in educational initiatives addressing the management of this disease.

His published work has included research and reviews concerning castration-resistant prostate cancer, an advanced form of prostate cancer that progresses despite androgen-deprivation treatment. A publication involving Dr. Smaletz examined systemic therapy approaches for this clinical situation and discussed the evolution of treatment strategies for patients with advanced disease.

He has also contributed to research concerning treatment decision-making in localized prostate cancer. A study published with his involvement evaluated the impact of pathology review on treatment decisions for patients with localized prostate cancer.

These academic contributions reflect the importance of individualized cancer treatment, where clinical decisions may depend on pathology, disease stage, tumor characteristics, patient health, and expected treatment benefits.

Expertise in Testicular Cancer

Dr. Oren Smaletz also has professional expertise in testicular cancer. He has participated as a faculty member and lecturer in oncology education programs addressing the diagnosis and treatment of testicular tumors.

At the Einstein Board Review in Medical Oncology, Dr. Smaletz has presented educational content concerning seminoma, a major type of testicular germ-cell tumor. Einstein's educational platform also identifies him as a clinical oncologist and author of educational material concerning testicular cancer.

Testicular cancer is relatively uncommon but frequently affects younger men. Diagnosis and treatment can involve urological evaluation, surgery, pathology, imaging, tumor-marker assessment, chemotherapy, radiation therapy in selected situations, and clinical surveillance depending on the tumor type and stage. Treatment decisions should always be individualized by the patient's multidisciplinary medical team.

Genitourinary Oncology and Cancer Research

Dr. Smaletz's professional interests extend across genitourinary oncology, including cancers involving the prostate, testicles, kidneys, and urinary system. His participation in Einstein educational programs has included discussions of renal and other genitourinary tumors. In one Einstein oncology event, he served as a coordinator alongside other oncology specialists for a program addressing contemporary approaches to kidney cancer, including genetic evaluation, active surveillance, surgery, adjuvant treatment, and metastatic disease.

His scientific profile also includes publications concerning cancer treatment and oncology research. Available academic records list numerous publications and citations associated with his work, including studies involving prostate cancer and other areas of oncology.

Medical Education and Academic Activities

In addition to patient care, Dr. Oren Smaletz has an active role in medical education and academic oncology. His official Einstein profile states that he is a doctoral student in the stricto sensu Medical Sciences Research program at the Israelita Institute of Teaching and Research Albert Einstein.

He has participated in oncology conferences, board-review programs, scientific meetings, and educational content designed for healthcare professionals. His involvement in these activities reflects the importance of continuing medical education in a rapidly evolving field such as oncology.

Cancer treatment is continually changing as new systemic therapies, biomarkers, molecular testing, immunotherapies, targeted treatments, and precision-medicine approaches become available. Dr. Smaletz has participated in professional discussions around these developments and the changing treatment landscape.

Precision Medicine and Modern Cancer Care

Modern oncology increasingly uses precision medicine to help match treatments to the biological characteristics of an individual patient's cancer. Dr. Smaletz has discussed the importance of molecular biomarkers and personalized treatment strategies in the context of cancer care at Einstein.

At Hospital Israelita Albert Einstein, oncology care incorporates multidisciplinary evaluation, advanced diagnostic resources, research, and evidence-based treatment. For suitable patients, modern cancer management may involve collaboration among medical oncologists, surgeons, radiation oncologists, radiologists, pathologists, genetic specialists, and other healthcare professionals.

Hospital Israelita Albert Einstein

Dr. Oren Smaletz currently works as a clinical oncologist at Hospital Israelita Albert Einstein in São Paulo, Brazil. His association with Einstein combines clinical cancer care with research and medical education.

For patients researching oncology treatment in Brazil, his profile is particularly relevant to those seeking specialized evaluation for prostate cancer, testicular cancer, and other genitourinary malignancies.

Key Areas of Expertise

  • Clinical Oncology

  • Medical Oncology

  • Genitourinary Oncology

  • Prostate Cancer

  • Testicular Cancer

  • Advanced Prostate Cancer

  • Castration-Resistant Prostate Cancer

  • Kidney Cancer

  • Systemic Cancer Treatment

  • Cancer Research

  • Precision Medicine

  • Oncology Education

  • Evidence-Based Cancer Care

  • Multidisciplinary Oncology

Why Consider Dr. Oren Smaletz?

Dr. Oren Smaletz combines a strong academic background with specialized oncology training and long-standing professional involvement in cancer medicine. He graduated from FMUSP, completed clinical medicine residency at Hospital das Clínicas, and received specialized clinical oncology training at Memorial Sloan Kettering Cancer Center in New York. He currently practices at Hospital Israelita Albert Einstein and remains involved in research and oncology education.

With particular expertise in genitourinary cancers, prostate cancer, and testicular cancer, Dr. Smaletz's profile is relevant for patients seeking specialized oncology consultation and treatment planning in São Paulo, Brazil. As with all cancer treatment, the appropriate therapy depends on the patient's individual diagnosis, disease stage, pathology, overall health, and treatment goals.

All reviews on Dr. Oren Smaletz
4.7
Patient reviews

Your trust is our top concern, so these reviews are from real people like you. We collect feedback only from our customers after getting medical services in the facility booked via Mespoir.com.

We publish both positive and negative reviews for you to make the best choice.

Reviews on Dr. Oren Smaletz

No Reviews!!

Blogs

Best Hospitals in India

Best Hospitals in India

📅 Last Updated : 2026-07-01 05:00:07
📖 Read Time : 11 min
🏷️ Category : hospitals

Read More

Best Cancer Hospitals in India

Best Cancer Hospitals in India

📅 Last Updated : 2026-08-12 05:04:45
📖 Read Time : 12min
🏷️ Category : hospitals

Read More

Best Hospitals in Spain

Best Hospitals in Spain

📅 Last Updated : 2026-07-03 14:50:43
📖 Read Time : 8min
🏷️ Category : hospitals

Read More

How Mespoir Can Help You

Mespoir is a leading global medical travel platform that provides assistance to over 8000 international patients every year:

network
Network Of Over 500 Hospitals

Mespoir has over 500 hospitals in its panel in over 10 countries ensure that the patients get to choose from many options.

concierge
Mespoir Concierge Support

Our experienced team consists of experience healthcare professionals and language experts who are available round the clock to assist our patients.

discount
Discounted Packages

We negotiate with the healthcare providers to provide discounted packages to our patients and corporate clients. The discount ranges from 10% to over 30% in some instances.

tax-free
No fees

Our medical travel consultations and concierge services are free of cost. We strongly thrive for complete transparency in the costs.

collage